Evolus (EOLS) Stock Chart & Stock Price History $11.72 +0.17 (+1.47%) As of 03:06 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Evolus Stock Price Performance 5 Day Performance+9.17%1 Month Performance-5.24%3 Month Performance-17.22%6 Month Performance-28.44%Year-To-Date Performance+6.69%1 Year Performance+2.78% Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. Email Address EOLS Stock Chart for Friday, April, 25, 2025 EOLS Chart by TradingView Evolus Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/24/2025$11.23$11.55+2.85%$11.77$11.15847,418 shs$734.43 million04/23/2025$10.46$11.23+7.36%$11.36$10.711.07 million shs$714.08 million04/22/2025$10.38$10.46+0.77%$10.74$10.36500,206 shs$665.12 million04/21/2025$10.79$10.38-3.80%$10.70$10.20657,859 shs$660.03 million04/18/2025$10.79$10.79$10.97$10.331.05 million shs$686.10 million04/17/2025$10.11$10.79+6.73%$10.97$10.331.05 million shs$686.10 million04/16/2025$10.23$10.11-1.17%$10.39$9.821.05 million shs$642.87 million04/15/2025$10.27$10.23-0.39%$10.49$9.92815,872 shs$650.50 million04/14/2025$9.54$10.27+7.65%$10.51$9.451.58 million shs$653.04 million04/11/2025$9.41$9.54+1.38%$9.94$9.061.12 million shs$606.62 million Get the Latest News and Ratings for EOLS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. 04/10/2025$10.37$9.41-9.26%$9.91$9.251.64 million shs$598.35 million04/09/2025$9.36$10.37+10.79%$10.52$8.672.00 million shs$659.40 million04/09/2025$9.36$10.37+10.79%$10.52$8.672.00 million shs$659.40 million04/08/2025$10.24$9.36-8.59%$10.71$9.311.36 million shs$595.17 million04/08/2025$10.24$9.36-8.59%$10.71$9.311.36 million shs$595.17 million04/07/2025$10.69$10.24-4.21%$10.74$9.691.08 million shs$651.13 million04/04/2025$11.39$10.69-6.15%$10.91$9.901.51 million shs$679.75 million04/03/2025$12.22$11.39-6.79%$12.00$11.121.27 million shs$724.26 million04/02/2025$11.99$12.22+1.92%$12.51$11.81876,656 shs$777.03 million04/01/2025$12.03$11.99-0.33%$12.26$11.82616,192 shs$762.41 million03/31/2025$12.05$12.03-0.17%$12.08$11.61534,673 shs$764.95 million03/28/2025$12.24$12.05-1.55%$12.33$11.59733,234 shs$766.22 million03/27/2025$12.43$12.24-1.53%$12.50$11.95822,459 shs$778.31 million03/26/2025$12.43$12.43$12.52$12.20328,932 shs$790.39 million03/25/2025$13.00$12.43-4.38%$13.10$12.32494,141 shs$790.39 million03/24/2025$13.03$13.00-0.23%$13.18$12.68527,447 shs$826.63 million Related Companies MoonLake Immunotherapeutics Stock Chart Alvotech Stock Chart Immunovant Stock Chart HUTCHMED Stock Chart ACADIA Pharmaceuticals Stock Chart Apellis Pharmaceuticals Stock Chart Amneal Pharmaceuticals Stock Chart Recursion Pharmaceuticals Stock Chart ImmunityBio Stock Chart Biohaven Stock Chart Receive EOLS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Evolus and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EOLS) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolus, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
